Two Phase 3 Trials Show Radiation Advances for Brain Metastases
Two phase 3 trials tested radiation approaches for brain metastases. Tile-based brachytherapy cut 1-year recurrence to 1.3% and improved median overall survival. Stereotactic radiation reduced symptom burden versus whole brain radiation.